General Medicine for NEET-PG
Tuberculosis and NTEP Regimens for NEET-PG
Tuberculosis and the National Tuberculosis Elimination Programme regimens are a high-yield NEET-PG topic that blends microbiology, pharmacology, and community medicine. The subject covers diagnosis, the daily fixed-dose regimen, drug-resistant tuberculosis, and the programme structure used across India, so questions span clinical and public-health angles. Because national programme details and drug adverse effects are frequently tested, the current regimen structure and the signature toxicity of each first-line drug are the key deliverables. Examiners favour the diagnostic role of molecular testing, the intensive and continuation phases, the management of drug-resistant disease, and treatment in special situations such as pregnancy and HIV coinfection. The topic links to HIV, hepatology, and preventive medicine. Common traps include quoting outdated intermittent regimens instead of the current daily fixed-dose combination approach, confusing which drug causes which toxicity, forgetting pyridoxine cover with isoniazid, and overlooking that rifampicin induces liver enzymes and reduces the efficacy of many co-administered drugs.
MedNext Academy | 3 min read
Tuberculosis and NTEP Regimens for NEET-PG
Tuberculosis and the National Tuberculosis Elimination Programme regimens are a high-yield NEET-PG topic that blends microbiology, pharmacology, and community medicine. The subject covers diagnosis, the daily fixed-dose regimen, drug-resistant tuberculosis, and the programme structure used across India, so questions span clinical and public-health angles. Because national programme details and drug adverse effects are frequently tested, the current regimen structure and the signature toxicity of each first-line drug are the key deliverables. Examiners favour the diagnostic role of molecular testing, the intensive and continuation phases, the management of drug-resistant disease, and treatment in special situations such as pregnancy and HIV coinfection. The topic links to HIV, hepatology, and preventive medicine. Common traps include quoting outdated intermittent regimens instead of the current daily fixed-dose combination approach, confusing which drug causes which toxicity, forgetting pyridoxine cover with isoniazid, and overlooking that rifampicin induces liver enzymes and reduces the efficacy of many co-administered drugs.
Tuberculosis and the National Tuberculosis Elimination Programme regimens are a high-yield NEET-PG topic that blends microbiology, pharmacology, and community medicine. The subject covers diagnosis, the daily fixed-dose regimen, drug-resistant tuberculosis, and the programme structure used across India, so questions span clinical and public-health angles. Because national programme details and drug adverse effects are frequently tested, the current regimen structure and the signature toxicity of each first-line drug are the key deliverables. Examiners favour the diagnostic role of molecular testing, the intensive and continuation phases, the management of drug-resistant disease, and treatment in special situations such as pregnancy and HIV coinfection. The topic links to HIV, hepatology, and preventive medicine. Common traps include quoting outdated intermittent regimens instead of the current daily fixed-dose combination approach, confusing which drug causes which toxicity, forgetting pyridoxine cover with isoniazid, and overlooking that rifampicin induces liver enzymes and reduces the efficacy of many co-administered drugs.
Key points
- **Diagnosis:** Molecular tests such as cartridge-based nucleic acid amplification detect tuberculosis and rifampicin resistance rapidly and are widely used under the programme.
- **Daily fixed-dose regimen:** Treatment uses daily fixed-dose combinations of first-line drugs, replacing the older intermittent thrice-weekly schedule.
- **Intensive phase:** Isoniazid, rifampicin, pyrazinamide, and ethambutol are given for the initial two months in new drug-sensitive cases.
- **Continuation phase:** Isoniazid, rifampicin, and ethambutol continue for the following four months in standard drug-sensitive disease.
- **Isoniazid:** Causes peripheral neuropathy through pyridoxine depletion and hepatotoxicity; pyridoxine is co-administered to prevent neuropathy.
- **Rifampicin:** Causes orange discolouration of secretions, hepatotoxicity, and strong enzyme induction that lowers levels of many drugs.
- **Ethambutol:** Causes dose-related optic neuritis with colour vision loss; visual acuity should be monitored.
- **Pyrazinamide:** Causes hyperuricaemia and hepatotoxicity; useful for sterilising activity in the intensive phase.
- **Drug-resistant tuberculosis:** Rifampicin-resistant and multidrug-resistant disease need longer regimens with newer agents such as bedaquiline under programme guidance.
- **HIV coinfection:** Tuberculosis is treated alongside antiretroviral therapy with attention to drug interactions, especially with rifampicin.
- **Pregnancy:** First-line drugs except streptomycin are considered safe; streptomycin is ototoxic to the foetus and avoided.
Frequently Asked Questions
What does the standard drug-sensitive tuberculosis regimen look like?
An intensive phase of isoniazid, rifampicin, pyrazinamide, and ethambutol for two months, then a continuation phase of isoniazid, rifampicin, and ethambutol for four months, given as daily fixed-dose combinations.
Which tuberculosis drug causes which toxicity?
Isoniazid causes neuropathy and hepatitis, rifampicin causes orange secretions and enzyme induction, ethambutol causes optic neuritis, and pyrazinamide causes hyperuricaemia and hepatitis.
Why is pyridoxine given with isoniazid?
Isoniazid increases pyridoxine excretion and can cause peripheral neuropathy. Co-administered pyridoxine prevents this, especially in those at higher risk such as diabetics and people with HIV.
How is drug-resistant tuberculosis handled?
Molecular tests identify rifampicin resistance early, and multidrug-resistant disease is treated with longer regimens including newer drugs such as bedaquiline under programme protocols.
Continue reading
NEET-PGComplete NEET-PG guide
Review the exam pattern, preparation and resources.
Practise General Medicine for NEET-PG
Explore clinician-written learning resources, structured revision and practice across the MedNext platform.
See plans